Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.
Brito-Zerón P, Acar-Denizli N, Romão VC, Armagan B, Seror R, Carubbi F, Melchor S, Priori R, Valim V, Retamozo S, Pasoto SG, Trevisani VFM, Hofauer B, Szántó A, Inanc N, Hernández-Molina G, Sebastian A, Bartoloni E, Devauchelle-Pensec V, Akasbi M, Giardina F, Bandeira M, Sisó-Almirall A, Ramos-Casals M; Sjögren Big Data Consortium. Brito-Zerón P, et al. Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):57-65. doi: 10.55563/clinexprheumatol/0anatx. Epub 2021 Nov 22. Clin Exp Rheumatol. 2021. PMID: 34874821 Free article.
Epidemiology of Sjögren's syndrome: where are we now?
Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A. Binard A, et al. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):1-4. Clin Exp Rheumatol. 2007. PMID: 17417982 Review. No abstract available.
European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
Seror R, Gottenberg JE, Devauchelle-Pensec V, Dubost JJ, Le Guern V, Hayem G, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Morel J, Pedriger A, Puechal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Zarnitsky C, Labetoulle M, Ravaud P, Mariette X. Seror R, et al. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1358-64. doi: 10.1002/acr.21991. Arthritis Care Res (Hoboken). 2013. PMID: 23436737 Free article.
Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X. Gottenberg JE, et al. PLoS One. 2013 May 24;8(5):e59868. doi: 10.1371/journal.pone.0059868. Print 2013. PLoS One. 2013. PMID: 23717383 Free PMC article.
Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg JE, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, Larroche C, Dubost JJ, Rist S, Saraux A, Devauchelle-Pensec V, Morel J, Hayem G, Hatron P, Perdriger A, Sene D, Zarnitsky C, Batouche D, Furlan V, Benessiano J, Perrodeau E, Seror R, Mariette X. Gottenberg JE, et al. JAMA. 2014 Jul 16;312(3):249-58. doi: 10.1001/jama.2014.7682. JAMA. 2014. PMID: 25027140 Clinical Trial.
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dörner T, Tzioufas A, Gottenberg JE, Solans Laqué R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zerón P, Vitali C, Mariette X; EULAR Sjögren's Task Force. Seror R, et al. Ann Rheum Dis. 2016 Feb;75(2):382-9. doi: 10.1136/annrheumdis-2014-206008. Epub 2014 Dec 5. Ann Rheum Dis. 2016. PMID: 25480887
Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.
Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A. Cornec D, et al. Rheumatology (Oxford). 2015 Sep;54(9):1699-708. doi: 10.1093/rheumatology/kev114. Epub 2015 May 8. Rheumatology (Oxford). 2015. PMID: 25957440 Clinical Trial.
221 results